This three day international academic congress will discuss current research and treatments being developed for Alzheimer’s Disease.
Topics for discussion include prediction and prevention strategies, vaccine development, drug discovery and care.
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding Alzheimer’s Disease.
Deadlines
The abstract submissions deadline for oral presentation is 10th March 2016
The early registration deadline is 20th April 2016
The Poster submission deadline in 26th May 2016
The 2016 Alzheimer’s Disease Congress has an open abstract session: Abstracts for oral or poster presentation can be submitted on any subject related to Alzheimer’s
This event is now over
There will be a meeting report in due course
For the follow up meeting please see www.lifescienceevents.com/alz2017
Talks include
| Talk Title | Speaker | Affiliation | Country |
|---|---|---|---|
| Calcium, Memory and Alzheimer's disease | Sir Michael Berridge | The Babraham Institute | United Kingdom |
| Drugs used in multiple pathologies, with stresses common to Alzheimers disease, offer candidate drugs and vaccine potential for Alzheimers disease | Professor Joan Smith Sonneborn | University of Wyoming | United States |
| Targeting Nucleophilic Attack During Early Beta-Amyloid Peptide Oligomerization | Adrien W. Schmid | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Switzerland |
| Neurophysiological vulnerability to aging associated with the Alzheimer’s risk variant in CLU gene | Dr Natalya Ponomareva | Research Center of Neurology | Russian Federation |
| The role of heparan sulfates in the amyloid pathology of Alzheimer disease | Charlotte Jendresen | University of Oslo and Oslo University Hospital | Norway |
| Cholesterol's contribution to autophagy deficits in Alzheimer’s disease | Dr Anna Colell | Spanish National Research Council (CSIC) | Spain |
| Granulovacuolar degeneration, a neurodegenerative change that accompanies tau pathology | Dr Christoph Köhler | University of Cologne | Germany |
| Looking for the markers of asymptomatic stage of Alzheimer's disease in the retina | Dr Slavica Krantic | UPMC | France |
| Sigma-1 receptor ligand Fluvoxamine modulates production of amyloid beta peptides in vitro and is protective in J20 Alzheimer disease mice | Associate Professor John BJ Kwok | Neuroscience Research Australia | Australia |
| Probing dementia-associated disruption of neural circuits using neurophysiology and imaging in murine models | Professor Andrew Randall | University of Exeter Medical School | United Kingdom |
| Link between the modifiable risk factors of Alzheimer's disease and neuroinflammation | Dr Andis Klegeris | University of British Columbia Okanagan Campus | Canada |
| Paradigm Shift: Semantic memory decline as a biomarker of preclinical Alzheimer’s disease | Professor Annalena Venneri | University of Sheffield | United Kingdom |
| The regulation of metastable proteins in neurodegenerative diseases | Rishika Kundra | University of Cambridge | United Kingdom |
| c-Abl signaling in Alzheimer's disease and other Neurodegenerative diseases: Projections for drugs searching | Dr Alejandra Alvarez R, Pontificia | Universidad Catolica de Chile | Chile |
| EEG biomarkers and profiling of AD mouse lines | Professor Bettina Platt | University of Aberdeen | United Kingdom |
| Potential therapeutic strategies of Cerebrolysin in Alzheimer's Disease | Dr Hari Shanker Sharm | Uppsala University | Sweden |
| Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis | Dr Vasiliki Orgeta | University College London | United Kingdom |
| Fighting Alzheimers Disease | Professor Michal Schwartz | The Weizmann Institute of Science | Israel |
| Smell identification function in Alzheimer's disease | Dr Latha Velayudhan | University of Leicester | United Kingdom |
| Multiple roles of cholinergic neurons in the modulation of amyloid production | Dr Jane Rylett | Schulich Medicine & Dentistry | Canada |
| Alpha2 adrenergic receptor as a novel target for Alzheimer's disease | Dr. Qin Wang | University of Alabama at Birmingham | United States |
| Associations of sorLA/SORL1 with Alzheimers disease | Dr. Olav Michael Anderse | Aarhus University | Denmark |
| Chaperoning Tau aggregation | Dr. Stefan Rüdiger | Utrecht University | Netherlands |
| The role of proliferating astrocytes in Alzheimer's disease | Dr Magdalena Sastre | Imperial College London | United Kingdom |
| Imaging-related biomarkers of cognitive decline in healthy controls. | Dr. Panteleimon Giannakopoulos | University Hospitals of Geneva | Switzerland |
| Inflammation in Dementia with Lewy bodies and Alzheimer's Disease | Dr Jay Amin | University of Southampton | United Kingdom |
| Dystrophic neurites are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation: the potential role of Aβ oligomers | Professor Robert Vassar, | Northwestern University Interdepartmental Neuroscience | United States |
| What makes an amyloidogenic protein toxic? Dissecting the sequence - self-assembly -toxicity relationship for amyloid peptides | Professor Louise Serpell | University of Sussex | United Kingdom |
| Loss of neuroprotective lipids and myelin as a key sensitizing factor in Alzheimer’s pathogenesis. | Dr Anthony Simon Don | University of New South Wales | Australia |
| Alzheimer's Disease: a clinical viewpoint | Dr Amit Arora | University Hospital of North Staffordshire | United Kingdom |
| The role of Pb in AD pathogenesis | Dr. Yansheng Du | Indiana University School of Medicine | United States |
| Computational studies on the toxicity mechanisms of amyloid beta peptides aggregation in relation to Alzheimer's disease | Professor Chew Lock Yue | Nanyang Technological University | Singapore |
| Type 2 diabetes mellitus accelerate tau pathology in nonhuman primate | Dr. Zhiming Zhang | University of Kentucky College of Medicine | United States |
| Is GluN2B-NMDA receptor a good target in treating Alzheimer's disease? | Professor Qiang Zhou | Peking University Shenzhen Graduate School | China |
| The drug therapy to increase stem cells for treatment of Alzheimer/s disease | Dr. Kiminobu Sugaya | University of Central Florida | United States |
| The involvement of type-1 interferon signalling and resultant neuroinflammation Alzheimer's Disease | Dr. Peter Crack | The University of Melbourne | Australia |
| Characterizing Prodromal Alzheimer's Disease Using Multimodality Imaging | Dr. Val Lowe | Mayo Clinic Rochester | United States |
| PET imaging biomarkers in Alzheimer's Disease | Professor Karl Herholz | University of Manchester | United Kingdom |
| Where did we go wrong in the study of APP processing | Dr. Ming Chen, | University of South Florida | United States |
| Good things in small packages: The molecular chaperone action of the small heat shock chaperone proteins | Professor Heath Ecroyd | University of Wollongong | Australia |
| Proteostasis Collapse and Protein Aggregation in Neurodegenerative Diseases | Dr. Justin Yerbury | University of Wollongong | Australia |
| Predicting Progression to Mild Cognitive Impairment in Cognitively Unimpaired Individuals Using Neuroimaging Biomarkers | Dr. Cynthia M. Stonnington | Mayo Clinic College of Medicine | United States |
| Biomedical nanotechnology and Alzheimer's. Can the disease be reversed? | Professor Christopher Whiteley | National Taiwan University of Science and Technology | Taiwan |
Advisory Board Members
| Name | Affiliation | Country |
|---|---|---|
| Professor Jordan L Holtzman | University of Minnesota | United States |
| Kaye Ervin | University of Melbourne | Australia |
| Dr Frank O. Bastian | LSU Agricultural Center | United States |
| Professor Sophia G. Antimisiaris | University of Patras | Greece |
| Professor Jane Mort | South Dakota State University | United States |
| Professor Urszula Wojda | Nencki Institute of Experimental Biology | Poland |
| Assistant Professor Myria Petrou | University of Michigan | United States |
| Dr Mourad Tayebi | Surrey University | United Kingdom |
| Dr Philip Liu | Mass General Hospital and Harvard Medical School | United States |
| Professor Mark R Wilson | University of Wollongong | Australia |
| Professor Qiang Zhou | Peking University Shenzhen Graduate School | China |
CPD Credits
| Credits from The Institute of Biomedical Science (code) | Approved by the Royal Society of Biology for purposes of CPD | ||
|---|---|---|---|
| 18(MD024N16) | This event may be counted as 54 CPD credits | ||
Related Past Event Agendas
Related past events
